Caitong International Asset Management Co., LTD Vertex Pharmaceuticals Inc Transaction History

Caitong International Asset Management Co., LTD

$144 Billion
Q3 2025

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Jul 31, 2025	BUY	$421.16 - $509.5 $67,385 - $81,520	160 New	160 $71.2 Million
Q4 2024 Feb 14, 2025	BUY	$396.64 - $516.74 $23,401 - $30,487	59 New	59 $23.8 Million

Others Institutions Holding VRTX

# of Institutions

1,806

Shares Held

231M

Call Options Held

1.83M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

25.9M
Shares

$11.2 Billion
1.45% of portfolio
Vanguard Group Inc Valley Forge, PA

24.2M
Shares

$10.5 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.25 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

16.6M
Shares

$7.18 Billion
1.27% of portfolio
State Street Corp Boston, MA

11.6M
Shares

$5.04 Billion
0.16% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitong International Asset Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Caitong International Asset Management Co., LTD with notifications on news.

Account